title: Plasmodium chabaudi chabaudi (AS): inflammatory cytokines and pathology in an erythrocytic-stage infection in mice.
abstract: We have sought to characterize Plasmodium chabaudi chabaudi infection in mice for use as a model for malaria pathology. Different mouse strains vary in their susceptibility to the erythrocytic stages of this parasite and this is manifested not only in the outcome of infection (survival versus death) but also by differences in the numbers of circulating parasites at the peak of infection. We have shown that regardless of final outcome, both resistant and susceptible mice exhibit other parameters of disease such as loss in body weight and anemia. By contrast, other parameters such as hypothermia appear more severe in susceptible mice. The severe symptoms coincide with high levels of inflammatory cytokines in the circulation of susceptible mice, not seen in H-2-matched resistant mice. However, levels of mRNA for the same cytokines, measured in the spleen of the same mice was not significantly different between the two strains. Neutralization of IFN-gamma in vivo led to an increase in parasitemia, in both susceptible and resistant mice, but did not affect the final outcome of disease. Indeed, symptoms were exacerbated in the absence of IFN-gamma, presumably because of larger numbers of circulating parasites. These data suggest that IFN-gamma does not directly contribute to the lethal outcome of infection in susceptible strains of mice.
authors.affiliation: Department of Biology, Imperial College of Science Technology and Medicine, Prince Consort Road, London, SW7 2BB, United Kingdom.
authors.forename: C E
authors.initials: CE
authors.lastname: Cross
authors.forename: J
authors.initials: J
authors.lastname: Langhorne
mesh_terms: D000740:Anemia / Q000209:etiology / Q000276:immunology; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D001831:Body Temperature; D016207:Cytokines / Q000032:analysis / Q000097:blood* / Q000235:genetics; D004195:Disease Models, Animal; D004198:Disease Susceptibility; D005260:Female; D007074:Immunoglobulin G / Q000276:immunology; D007371:Interferon-gamma / Q000097:blood / Q000276:immunology; D008288:Malaria / Q000150:complications / Q000276:immunology* / Q000503:physiopathology; D008297:Male; D051379:Mice; D008805:Mice, Inbred A; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D018512:Parasitemia / Q000276:immunology* / Q000503:physiopathology; D016788:Plasmodium chabaudi / Q000276:immunology / Q000472:pathogenicity*; D011379:Prognosis; D012333:RNA, Messenger / Q000032:analysis; D012737:Sex Factors; D013154:Spleen / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis; D015431:Weight Loss
chemical_list: D000911:Antibodies, Monoclonal; D016207:Cytokines; D007074:Immunoglobulin G; D012333:RNA, Messenger; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma